Skip to main content
TipRanks
Go Ultimate75% OFF

Michael Bergeron Insider Profile

4 Followers

Michael Bergeron, SVP, WW Sales and Field Oper at Dolby Laboratories, holds 47.50K shares in Dolby Laboratories (Ticker: DLB).

Michael Bergeron's Trading History

DLB
Dolby Laboratories
Aug 18, 2016SVP, WW Sales and Field OperUninformative Buy1.16M$3.07M
DLB
Insider Shares: 47.50K (0.08%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Aug 18, 2016Informative Sell$2.45M50,000$49.09+1.70%
Aug 18, 2016Uninformative Buy$1.16M30,951$37.53―
Aug 10, 2016Informative Sell$3.40M68,161$49.83-1.60%
Aug 10, 2016Uninformative Buy$2.06M67,400$30.49―
May 18, 2016Informative Sell$2.25M50,000$45.01-13.40%

You May Also Like

Michael Bergeron insider profile FAQ

What is the percentage of profitable transactions made by Michael Bergeron?
The percentage of profitable transactions made by Michael Bergeron is 50%.
What is the average return per transaction made by Michael Bergeron?
The average return per transaction made by Michael Bergeron is 2.70%.
What stocks does Michael Bergeron hold?
Michael Bergeron holds: DLB stocks.
What was Michael Bergeron’s latest transaction?
Michael Bergeron’s latest transaction was an Uninformative Buy of $1.16M.
What was Michael Bergeron's most profitable transaction?
Michael Bergeron’s most profitable transaction was an Informative Sell of DLB stock on August 14, 2014. The return on the trade was 24.40%.
What is Michael Bergeron's role in Dolby Laboratories?
Michael Bergeron's role in Dolby Laboratories is SVP, WW Sales and Field Oper.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.